Post Subject #222751   0 SGYP files bankruptcy, Bausch Health takes remaining assets. Synergy biotech_researcher 12/12/18 07:30:02 AM #222750   0 ACIU > AC Immune and Lilly Announce License biocqr 12/12/18 07:27:29 AM #222730   0 Corteva—the ag-biotech company to be spun from DWDP DewDiligence 12/10/18 07:57:05 PM #222644   0 Re: Rationale for owning RVNC (addendum to #msg-144655043) DewDiligence 12/04/18 07:08:05 PM #222600   0 Revance’s RT002 Demonstrates Unprecedented Efficacy and Duration In hptaxis 12/04/18 08:15:07 AM #220844   0 Allergan pursuit of longer-acting toxin not a risk jbog 09/14/18 11:13:21 AM #222756   0 [OT]How drug companies make you buy more medicine Titan V 12/12/18 01:16:48 PM #222755   0 i believe seth klarman is a major holder linhdtu 12/12/18 11:08:44 AM #222754   0 NBIX -21%/PM on phase-2b failure in pediatric Tourette syndrome: DewDiligence 12/12/18 09:20:20 AM #222753   0 Recent Biotech Bankruptcies/Liquidations/Dissolutions DewDiligence 12/12/18 08:42:03 AM #222752   0 FDA Rolls Out Expectations for Biosimilars, Soon-to-Be Biologics biotech_researcher 12/12/18 08:27:03 AM #222751   0 SGYP files bankruptcy, Bausch Health takes remaining assets. Synergy biotech_researcher 12/12/18 07:30:02 AM #222750   0 ACIU > AC Immune and Lilly Announce License biocqr 12/12/18 07:27:29 AM #222749   0 CORT:earlier this year, Cushing's Syndrome and drug to north40000 12/11/18 08:44:18 PM #222748   0 CORT +32% on issuance of US patent, which DewDiligence 12/11/18 06:59:51 PM #222747   0 Nice try also: All quoted material was contained north40000 12/11/18 06:46:17 PM #222746   0 Nice try, but the text you highlighted in DewDiligence 12/11/18 05:15:00 PM #222745   0 It does pay to read to the end north40000 12/11/18 05:09:21 PM #222744   0 You changed the subject, LOL. The ONCS PR DewDiligence 12/11/18 05:05:12 PM #222743   0 Now in phase 1 and 2 clinical trials, north40000 12/11/18 04:56:32 PM #222742   0 (ONCS)—Pharmacodynamic data don’t tell us whether there will DewDiligence 12/11/18 04:49:24 PM #222741   0 MRK/ONCS: Comments? This news looks significant to me north40000 12/11/18 04:37:16 PM #222740   0 mr. o... jessellivermore 12/11/18 04:17:45 PM #222739   0 hahaha wrt to revance i consider retailers to linhdtu 12/11/18 01:10:39 PM #222738   0 RVNC trading up to Sakura safety results was Bickema 12/11/18 01:01:02 PM #222737   0 It’s mainly YE tax loss sales as many kris_kade 12/11/18 12:59:19 PM #222736   0 Looks like everyone forgot about Revance. jbog 12/11/18 12:24:17 PM #222735   0 AFMD - R&D day slide deck semi_infinite 12/11/18 12:18:10 PM #222734   0 https://tinyurl.com/y9mllgek sab63090 12/11/18 10:41:39 AM #222733   0 PTLA -7%—CHMP extends review of Ondexxa (proposed EU DewDiligence 12/11/18 09:39:30 AM #222732   0 JL, what does Vascepa cost you per month? mr_o 12/10/18 08:45:48 PM #222731   0 Thanks. I didn't think GRTS had much, if DewDiligence 12/10/18 07:58:28 PM #222730   0 Corteva—the ag-biotech company to be spun from DWDP DewDiligence 12/10/18 07:57:05 PM #222729   0 GRTS. ..Dew ..think this is more related to Whalatane 12/10/18 04:10:57 PM #222728   0 GNBT—Oops: https://www.businesswire.com/news/home/20181210005781/en On DewDiligence 12/10/18 03:43:50 PM #222727   0 GRTS -14% on seemingly ho-hum PR: DewDiligence 12/10/18 12:00:07 PM #222726   0 MGNX -27% on partial clinical hold announced Friday DewDiligence 12/10/18 11:55:37 AM #222725   0 Thanks JL. Great info. randychub 12/10/18 09:40:45 AM #222724   0 Who would you acquire if you were Mr. O'Day? Bickema 12/10/18 09:35:13 AM #222723   0 AXON -22%/PM on phase-2 failure: DewDiligence 12/10/18 08:32:43 AM #222722   0 Big pressure on the generics: biotech_researcher 12/10/18 07:33:56 AM #222720   0 GILD’s incoming CEO<—Roche executive, Daniel O’Day (according to WSJ): DewDiligence 12/09/18 08:47:18 PM #222719   0 THOR too busy to put their data on dangerM 12/09/18 08:19:49 PM #222718   0 I predict that, when all is said and DewDiligence 12/09/18 08:15:28 PM #222717   0 Agree. <eom> kris_kade 12/09/18 07:49:39 PM #222716   0 Aside from the date comments are due I'm dewophile 12/09/18 04:14:52 PM #222715   0 Another tweet suggests that proposed rule available below, mouton29 12/09/18 04:13:24 PM #222714   0 Probably you are correct, but there are some mouton29 12/09/18 01:03:00 PM #222713   0 This is old news dewophile 12/09/18 10:40:25 AM #222712   0 “DMA.V/DMAC sells 4.1M shares @$4.00 in US IPO” This FreeNorth 12/08/18 06:41:59 PM #222711   0 Trump admin seeks to severely limit all biotech biotech_researcher 12/08/18 02:50:38 PM #222710   0 Not for US or ROW bio companies. Actually kris_kade 12/08/18 02:38:09 PM #222709   0 Bad news for biotech if true: Kenneth Harris (@kharrisCellMed) 12/7/18, biotech_researcher 12/08/18 11:05:58 AM #222708   0 https://www.yahoo.com/gma/2nd-deadliest-ebola-outbreak-history-spreads-major-cit Preciouslife1 12/08/18 07:19:18 AM #222707   0 randy... Sjorgren's Syndrome (SS)..is generally though of to be jessellivermore 12/08/18 06:47:33 AM #222706   0 Matthew Herper (@matthewherper) 12/7/18, 11:01 AM Some personal news. After biotech_researcher 12/07/18 08:21:55 PM Post Subject

© 2018 InvestorsHub.com, Inc.